Literature DB >> 30483316

Upper Limb Deep Vein Thrombosis: A Case Report of an Increasingly Common Condition.

Alexander W Y Chen1, Kaveh Oraii Yazdani2, Luciano Candilio1.   

Abstract

Upper limb deep vein thrombosis (DVT) is a less common phenomenon than lower limb DVT. Repeated trauma secondary to sport- or job-related arm movements and positions has been recognized as the predisposing factor for upper limb DVT. We describe a 38-year-old male computer programmer admitted with swelling and pain in his left upper limb. Venous duplex ultrasound confirmed the presence of axillary vein thrombosis. Coagulation studies for secondary thrombosis were unremarkable. The patient was treated with full anticoagulation using low molecular weight heparin and warfarin. On subsequent follow-up at 3 months, the patient was symptom free and duplex sonography showed no evidence of thrombosis.

Entities:  

Keywords:  Axillary vein; Subclavian vein; Thromboembolism; Upper extremity deep vein thrombosis

Year:  2018        PMID: 30483316      PMCID: PMC6246438     

Source DB:  PubMed          Journal:  J Tehran Heart Cent        ISSN: 1735-5370


Introduction

Lower limb deep vein thrombosis (DVT) is a common and well-described condition which has recently grown in public awareness. The risk factors for lower limb DVT arise from the underlying components of Virchow’s triad: venous stasis, hypercoagulability, and injury to the intima of veins. Upper limb thrombosis, involving the axillary or subclavian vein, is a less common phenomenon.[1] This condition is subject to the same risk factors as the formation of lower limb DVT. Another way of assessing the risk factors for upper limb DVT is by considering endogenous (e.g., thrombophilia and pregnancy) and exogenous (e.g., external compression of the vein by the cervical rib or a solid tumor) causes, although it may occur spontaneously.[2] The relatively fixed position of the axillo-subclavian vein in the thoracic inlet/outlet predisposes it to repeated trauma with arm movements, leading to the compression of the vein in the costo-clavicular space. The axillo-subclavian compression between the clavicle and the first rib may also be exaggerated with frequent strenuous arm movements (e.g., tennis and body building) or when the upper extremity is in particular positions such as the rigid military style of sitting with the back straight and the shoulders placed posteriorly and inferiorly (e.g., sitting at a computer desk).[3] We report a case of spontaneous axillary vein thrombosis and predict that the incidence of this condition will increase.

Case Report

A 38-year-old left-hand dominant man woke up with acute pain and swelling in his left upper limb. He was a computer programmer and, additionally, used to work as a disc jockey in a local nightclub every weekend. He had no intrinsic risk factors for thromboembolic disease but spent prolonged periods of the day with his upper limbs in a relatively stationary position whilst using a computer keyboard. Physical examination revealed erythema, heat, swelling, and tenderness localized to the ulna border of his left arm (Figure 1). There was no systemic feature of illness.
Figure 1

Patient’s left arm appearance at presentation

Patient’s left arm appearance at presentation Laboratory tests including routine full blood count, renal and liver profiles, inflammatory markers, thrombophilia test, and viral screen were unremarkable, with the exception of elevated D-dimer. Venous duplex ultrasound of his left arm demonstrated compressible radial, ulnar, and brachial veins with decreased compressibility in the left axillary vein and confirmed the presence of thrombosis extending throughout the length of the vessel. Although there was no obvious symptom or sign of pulmonary embolism, we decided to proceed with computed tomography pulmonary angiography (CTPA), given the patient’s Wells score of 3 (proven DVT), which corresponds to an intermediate risk category for pulmonary embolism (score ≥2 and ≤6).[4] CTPA showed no evidence of pulmonary embolism. We treated the patient with full anticoagulation using subcutaneous low molecular weight heparin and oral warfarin, and his signs and symptoms gradually resolved over the next few days. On subsequent follow-up at 3 months, he remained well and asymptomatic and repeated venous Doppler ultrasound revealed complete resolution of the left axillary thrombosis. Following the guidelines from the American College of Chest Physicians, which recommend anticoagulation for a minimum of 3 months for all patients identified with uncomplicated primary upper extremity DVT, we discontinued his warfarin.[5]

Discussion

Thrombosis of the subclavian vein was first described in 1875 by Sir James Paget,[6] who named it “gouty phlebitis”. However, he incorrectly attributed this syndrome to vasospasm rather than to thrombosis. In 1884, von Schrötter[7] independently described this condition and postulated that it resulted from occlusive thrombosis of the subclavian or axillary veins. In recognition of these physicians, Hughes[8] coined the term “Paget–Schrötter syndrome” in 1949 to describe the syndrome of spontaneous primary thrombosis of the axillary or subclavian vein. The estimated incidence of DVT from all causes is 131.5 per 100 000 person-years. Nonetheless, this may be an underestimation because a number of DVTs remain asymptomatic and therefore undiagnosed.[9] Prior to 1967, thrombosis of the axillary or subclavian vein was estimated to account for 1% to 2% of all DVTs. Since then, its incidence has risen due to increasing usage of central venous cannulation (CVC) and it is now estimated that upper limb DVT makes up 4% to 10% of all episodes of DVTs, with an approximate annual incidence of 3.6 per 100 000 persons.[10] Thrombosis is thought to occur in the dominant arm in 80% of cases.[3] A thorough history taking and an appropriate physical examination are usually sufficient to suggest this diagnosis.[11] This may then be confirmed with a venogram or venous ultrasound scan. Differentiating between primary and secondary upper limb venous thrombosis is crucial in view of their different natural histories. Primary thrombosis accounts for 20% to 50% of all upper limb DVT s.[10], [12] It includes real idiopathic cases and Paget–Schrötter syndrome, which is attributed to repetitive effort. Major risk factors for secondary DVT are CVC, cancer, and upper extremity surgery.[13] Approximately, between 30% and 40% of all upper limb DVTs are cancer-related and 70% of secondary cases are related to CVC.[14] In a study, 38.5% of the patients who had a peripherally inserted central catheter line developed upper limb DVTs.[15] As is the case for lower limb DVT, the diagnosis of upper limb DVT is crucial considering its potentially life-threatening complications such as pulmonary thromboembolism.[16] We predict that the incidence of upper limb DVT as a whole will increase. The incidence of secondary upper limb DVT will increase due to more frequent usage of subclavian vein catheters, especially in patients with cancers, who are already at higher risk of developing this condition. The use of permanent pacemakers is also increasing, which will further add to the incidence of this disease. With our population’s increasingly sedentary lifestyle and the increasing employment opportunities in the information-technology industry with repetitive workload on the upper limb in an almost fixed position, we predict that the future will yield many more similar cases to our case report.

Conclusion

Upper limb thrombosis is a less known and rarer condition than lower limb thrombosis and has been particularly associated with exogenous factors, including sports and occupation. Nevertheless, diagnosis of upper limb DVT is similarly crucial, and recognition and treatment of potential complications such as pulmonary embolism are vital.
  16 in total

1.  Upper-extremity deep vein thrombosis: a prospective registry of 592 patients.

Authors:  Hylton V Joffe; Nils Kucher; Victor F Tapson; Samuel Z Goldhaber
Journal:  Circulation       Date:  2004-09-07       Impact factor: 29.690

2.  Paget-von Schrötter syndrome.

Authors:  Igor Maslovsky; Dov Gefel
Journal:  Am J Med       Date:  2006-04       Impact factor: 4.965

3.  Venous obstruction in the upper extremity; Paget-Schroetter's syndrome; a review of 320 cases.

Authors:  E S R HUGHES
Journal:  Surg Gynecol Obstet       Date:  1949-02

4.  Sir james paget.

Authors:  Siddharth Pramod Dubhashi; Rajat Dinesh Sindwani
Journal:  Indian J Surg       Date:  2014-06       Impact factor: 0.656

5.  Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer.

Authors:  P S Wells; D R Anderson; M Rodger; J S Ginsberg; C Kearon; M Gent; A G Turpie; J Bormanis; J Weitz; M Chamberlain; D Bowie; D Barnes; J Hirsh
Journal:  Thromb Haemost       Date:  2000-03       Impact factor: 5.249

6.  Upper extremity deep venous thrombosis and its impact on morbidity and mortality rates in a hospital-based population.

Authors:  A Hingorani; E Ascher; E Lorenson; P DePippo; S Salles-Cunha; M Scheinman; W Yorkovich; J Hanson
Journal:  J Vasc Surg       Date:  1997-11       Impact factor: 4.268

7.  Current management strategies and long-term clinical outcomes of upper extremity venous thrombosis.

Authors:  S M Bleker; N van Es; A Kleinjan; H R Büller; P W Kamphuisen; A Aggarwal; J Beyer-Westendorf; G Camporese; B Cosmi; T Gary; A Ghirarduzzi; K Kaasjager; T Lerede; P Marschang; K Meijer; H-M Otten; E Porreca; M Righini; P Verhamme; S van Wissen; M Di Nisio
Journal:  J Thromb Haemost       Date:  2016-04-04       Impact factor: 5.824

8.  Upper extremity deep venous thrombosis in the population-based Malmö thrombophilia study (MATS). Epidemiology, risk factors, recurrence risk, and mortality.

Authors:  Nazim Isma; Peter J Svensson; Anders Gottsäter; Bengt Lindblad
Journal:  Thromb Res       Date:  2010-04-20       Impact factor: 3.944

Review 9.  A comprehensive review of Paget-Schroetter syndrome.

Authors:  Karl A Illig; Adam J Doyle
Journal:  J Vasc Surg       Date:  2010-03-20       Impact factor: 4.268

10.  Epidemiology of first and recurrent venous thromboembolism: a population-based cohort study in patients without active cancer.

Authors:  C Martinez; A T Cohen; L Bamber; S Rietbrock
Journal:  Thromb Haemost       Date:  2014-04-03       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.